Exclusive: What kills a Life Sciences start-up?

Mistakes are unavoidable in an entrepreneurial journey. Some mistakes are significant and others -- though insignificant -- can act as a pillar for learning


(Photo Courtesy: www.bizpacreview.com)

But often times those mistakes end up being costly and start-ups and organizations have paid heavy price all throughout history. Learning from mistakes and avoiding them the second time sounds wise.

But what if an entrepreneur can identify the tell-tale signs of the end-game earlier? Is it possible to resurrect a dying or a dead Life Sciences start-up? What'd it take to make a big comeback on the scene to slay newer and bigger dragons? BioSpectrum's Raj Gunashekar finds out.

Dying Signs

An unstable team is perceived as the first sign of a dying start-up which displays a teams' disbelief in their venture.

"Lack of skilled personnel in the core technology is another indication that a venture is in trouble. Apart from the aforesaid point, lack of market space for the developed product is a clear sign of a dying start-up," comments Dr Kavitha Sairam, Director, FIB-SOL Life Technologies.

Pushing on outdated scientific concepts, working on old technology platforms, and difficulty in attracting funding or top talents are the symptoms of a dying start-up, says Mr Sam Santhosh, Chairman, MedGenome.


Previous 1 3 4 5 6 7 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email